IV access port cap for providing antimicrobial protection

US9283369B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9283369-B2
Application numberUS-201414185827-A
CountryUS
Kind codeB2
Filing dateFeb 20, 2014
Priority dateFeb 20, 2014
Publication dateMar 15, 2016
Grant dateMar 15, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A cap is configured to provide antimicrobial protection to a female luer port of an intravenous device. The cap distributes an antimicrobial solution within the intraluminal surfaces of the port when the cap is connected to the port. A cap may also be designed to distribute an antimicrobial solution around the exterior surfaces of the port. Once connected to a port, the cap can form a seal that minimizes the evaporation of the antimicrobial solution from within the lumen of a port. The cap can therefore provide antimicrobial protection against another device that is connected to the port once the cap is removed.

First claim

Opening claim text (preview).

The invention claimed is: 1. A cap for a port of an intravenous device, the cap comprising: a body having a proximal end and a distal end, the body including a cavity formed in the distal end of the body; an actuator having a proximal end and a distal end, the proximal end of the actuator being contained within the cavity, the distal end of the actuator extending out from the cavity and being configured to insert into the port of the intravenous device, the proximal end of the actuator being configured to move within the cavity between a distal position and a proximal position; and an absorbent material containing an antimicrobial solution, the absorbent material being contained within the cavity between the proximal end of the body and the proximal end of the actuator, the absorbent material being compressible; wherein when the cap is connected to the port of the intravenous device, the proximal end of the actuator is advanced proximally into the cavity from the distal position to the proximal position thereby compressing the absorbent material causing the antimicrobial solution to flow through the distal end of the actuator and onto an intraluminal surface of the port. 2. The cap of claim 1 , wherein the distal end of the actuator comprises a lumen, the antimicrobial solution flowing through the lumen into a lumen of the port. 3. The cap of claim 2 , wherein the distal end of the actuator comprises a male luer in which the lumen is formed. 4. The cap of claim 1 , wherein the proximal end of the actuator is configured such that a gap exists between the proximal end of the actuator and an inner surface of the cavity as the proximal end of the actuator is advanced towards the proximal position, and wherein the antimicrobial solution flows through the gap and onto an exterior surface of the port. 5. The cap of claim 1 , wherein, when in the proximal position, the proximal end of the actuator contacts an inner surface of the cavity thereby forming a seal between the actuator and the body. 6. The cap of claim 1 , wherein the concentration of an antimicrobial agent within the antimicrobial solution is selected such that when the antimicrobial solution mixes with fluid contained within the lumen of the port, the concentration of the antimicrobial agent remains higher than the minimum inhibitory concentration of the antimicrobial agent. 7. The cap of claim 1 , wherein the port is a female luer into which the distal end of the actuator inserts. 8. The cap of claim 1 , wherein the port is a needleless connector into which the distal end of the actuator inserts. 9. The cap of claim 1 , wherein the distal end of the body forms a lumen, and wherein the distal end of the actuator forms a protrusion that is positioned within the lumen formed by the distal end of the body, the protrusion having a lumen through which the antimicrobial solution flows. 10. The cap of claim 9 , wherein the actuator includes a plurality of prongs that extend through corresponding openings in the distal end of the body. 11. The cap of claim 10 , wherein the antimicrobial solution flows through the openings when the proximal end of the actuator is advanced proximally into the cavity. 12. The cap of claim 1 , wherein the distal end of the actuator includes a lumen, the lumen having an antimicrobial coating. 13. A cap for a port of an intravenous device, the cap comprising: a body having a proximal end and a distal end, the body including a cavity formed in the distal end of the body; an actuator having a proximal end and a distal end, the proximal end of the actuator being contained within the cavity, the distal end of the actuator extending out from the cavity and being configured to insert into the port of the intravenous device, the distal end of the actuator including a lumen, the proximal end of the actuator being configured to move within the cavity between a distal position and a proximal position; and an absorbent material containing an antimicrobial solution, the absorbent material being contained within the cavity between the proximal end of the actuator and an inner surface of the body; wherein prior to the cap being connected to the port of the intravenous device, the absorbent material remains uncompressed, and when the cap is connected to the port of the intravenous device, the actuator compresses the absorbent material causing the antimicrobial solution to flow through the lumen of the distal end of the actuator and into a lumen of the port. 14. The cap of claim 13 , wherein the proximal end of the actuator is sized such that a gap exists between an outer edge of the proximal end of the actuator and a wall of the cavity, the antimicrobial solution also flowing through the gap onto an exterior surface of the port. 15. The cap of claim 14 , wherein the actuator includes a plurality of prongs which extend through corresponding openings in the body, the antimicrobial solution flowing through the openings onto the exterior surface of the port. 16. The cap of claim 13 , wherein, when in the proximal position, the proximal end of the actuator forms a seal with an inner surface of the cavity. 17. The cap of claim 13 , wherein the distal end of the actuator comprises a male luer. 18. A cap for a needleless connector of an intravenous device, the cap comprising: a body having a proximal end and a distal end, the body including a cavity formed in the distal end of the body; an absorbent material positioned within the cavity, the absorbent material containing an antimicrobial solution; and an actuator having a proximal end and a distal end, the proximal end of the actuator being contained within the cavity, the distal end of the actuator extending out from the cavity and being configured to insert into the needleless connector, the proximal end of the actuator being configured to move within the cavity between a distal position and a proximal position such that upon the cap being connected to the needleless connector, the needleless connector causes the proximal end of the actuator to compress the absorbent material thereby releasing the antimicrobial solution onto an intraluminal surface of the needleless connector. 19. The cap of claim 18 , wherein the distal end of the actuator comprises a lumen, the antimicrobial solution flowing through the lumen of the distal end of the actuator and onto the intraluminal surface of the needleless connector. 20. The cap of claim 19 , wherein the antimicrobial solution also flows around an exterior surface of the proximal end of the actuator and onto an exterior surface of the needleless connector.

Assignees

Inventors

Classifications

  • provided with an antibacterial agent, e.g. by coating, residing in the polymer matrix or releasing an agent out of a reservoir · CPC title

  • A61M39/162Primary

    with antiseptic agent incorporated within the connector · CPC title

  • Shrouds or protectors for aseptically enclosing the connector · CPC title

  • specially adapted for long-term hygiene care, e.g. urethral or indwelling catheters to prevent infections · CPC title

  • A61M39/20Primary

    Closure caps or plugs for connectors or open ends of tubes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9283369B2 cover?
A cap is configured to provide antimicrobial protection to a female luer port of an intravenous device. The cap distributes an antimicrobial solution within the intraluminal surfaces of the port when the cap is connected to the port. A cap may also be designed to distribute an antimicrobial solution around the exterior surfaces of the port. Once connected to a port, the cap can form a seal that…
Who is the assignee on this patent?
Becton Dickinson Co
What technology area does this patent fall under?
Primary CPC classification A61M39/162. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).